We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




David Pall, Founder of Pall Corporation, Dies at 90.

By Labmedica staff writers
Posted on 07 Oct 2004
Dr. More...
David B. Pall, a chemist who founded the Pall Corporation in 1946 to commercialize his invention of a novel metallic filtration material, died on September 21, 2004, at his home in Roslyn Estates (NY, USA). He was 90.

David Boris Pall was born in Thunder Bay, Ontario (Canada) in April 1914, the son of Russian immigrants. He received his Ph.D. in physical chemistry from McGill University (Montreal) in 1939. After that, he moved to New York (NY, USA), where he worked as a research chemist on the Manhattan Project, a secret program resulting in the development of the atomic bomb.

In 1944, Dr. Pall began working in his garage on a metallic filter that would be able to handle heavy pressure, high temperatures, and corrosive materials. He invented many different kinds of filters and received 181 U.S. patents on his designs. Some designs were for filters used aboard airplanes or on helicopter engines. After his first wife, Josephine, died of plastic anemia, he invented filters for purifying blood used in transfusions that have made the procedure much safer by protecting transfused patients from viruses and other harmful pathogens.

Dr. Pall established a company called the Micro Metallic Corp. in East Hills, NY (USA) to distribute his new designs. The name was later changed to the Pall Corporation, which grew into a global company and a world leader in filtration under his tenure. In 1990, Dr. Pall was awarded the U.S. National Medal of Technology, the nation's highest honor in technology. Dr. Pall retired as chairman of Pall Corporation in 1992.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.